Literature DB >> 30885617

Severe coagulopathy in Merrem's hump-nosed pit viper (Hypnale hypnale) envenoming unresponsive to fresh frozen plasma: A case report.

Harendra Kumara1, Nimal Seneviratne2, Dilini S Jayaratne2, Sisira Siribaddana3, Geoffrey K Isbister4, Anjana Silva5.   

Abstract

The Merrem's hump-nosed viper (H. hypnale) causes many snakebites in South India and Sri Lanka. At present no antivenom is available for envenomings by this snake. A 42-year-old male bitten by a large H. hypnale, presented within 30 min of the bite and had a cardiac arrest soon after admission. This responded to standard advanced life support, but he had an unrecordably high international normalised ratio (INR), activated partial thromboplastin time and unrecordably low fibrinogen, consistent with a complete venom-induced consumption coagulopathy. In the absence of antivenom, a total of 1680ml of fresh frozen plasma (FFP) was transfused 5.5 and 16 h post-bite. The coagulopathy did not improve with the administration of FFP and a further elevation of D-Dimer after FFP suggested consumption of transfused clotting factors. The coagulopathy resolved after 72 h. The patient did not develop any bleeding complications, acute kidney injury or evidence of thrombotic microangiopathy and was discharged 8 days after the bite. This case suggests that early FFP for VICC in H. hypnale envenoming may worsen the coagulopathy in the absence of antivenom and cannot be recommended.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Cardiac arrest; Coagulopathy; Fresh frozen plasma; H hypnale

Mesh:

Substances:

Year:  2019        PMID: 30885617     DOI: 10.1016/j.toxicon.2019.03.015

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  1 in total

1.  A simple mortality risk prediction score for viper envenoming in India (VENOMS): A model development and validation study.

Authors:  Maya Gopalakrishnan; Suman Saurabh; Pramod Sagar; Chanaveerappa Bammigatti; Tarun Kumar Dutta
Journal:  PLoS Negl Trop Dis       Date:  2022-02-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.